Literature DB >> 20140473

Diffuse systemic sclerosis and autoimmune hepatitis: a unique association.

Carlos Ewerton Maia Rodrigues1, Cláudia Lobato Borges, Jozélio Freire de Carvalho.   

Abstract

Autoimmune hepatitis (AIH) is a chronic hepatitis of unknown etiology characterized by continuing hepatocellular necrosis and inflammation that afflicts 100,000 to 200,000 persons in the United States. It is a rare manifestation of systemic sclerosis. Only about nine reports of this association have been previously reported in the literature. Importantly, all cases had the limited clinical form of systemic. The authors describe herein the first report of a patient with diffuse systemic sclerosis who was diagnosed with AIH with positive antimitochondrial antibody and had an excellent response to immunosuppressive drugs. We also briefly review the literature regarding this issue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140473     DOI: 10.1007/s10067-010-1390-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  A case of CREST syndrome with rapidly progressive liver damage.

Authors:  H Yabe; K Noma; N Tada; S Mochizuki; M Nagano
Journal:  Intern Med       Date:  1992-01       Impact factor: 1.271

2.  [Scleroderma-like lesions in the course of autoimmune hepatitis. Case report].

Authors:  Joanna Narbutt; Aleksandra Lesiak; Aneta Kwiecień; Anna Sysa-Jedrzejowska; Jan Kuydowicz
Journal:  Przegl Lek       Date:  2005

3.  [Autoimmune hepatitis and morphea: a rare association].

Authors:  Mabrouk Khalifa; Elhem Ben Jazia; Wissem Hachfi; Badreddine Sriha; Fethi Bahri; Amel Letaief
Journal:  Gastroenterol Clin Biol       Date:  2006 Jun-Jul

4.  Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome?

Authors:  I Marie; H Levesque; J L Tranvouez; A François; G Riachi; N Cailleux; H Courtois
Journal:  Rheumatology (Oxford)       Date:  2001-01       Impact factor: 7.580

5.  CRST syndrome (calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis.

Authors:  M Ishikawa; J Okada; A Shibuya; H Kondo
Journal:  Intern Med       Date:  1995-01       Impact factor: 1.271

6.  Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

Authors:  W A D'Angelo; J F Fries; A T Masi; L E Shulman
Journal:  Am J Med       Date:  1969-03       Impact factor: 4.965

Review 7.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  M Abu-Shakra; F Guillemin; P Lee
Journal:  Semin Arthritis Rheum       Date:  1994-08       Impact factor: 5.532

8.  Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.

Authors:  Aldo J Montano-Loza; Herschel A Carpenter; Albert J Czaja
Journal:  J Clin Gastroenterol       Date:  2008-10       Impact factor: 3.062

9.  Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  1998-09

10.  [Autoimmune hepatitis and CREST syndrome].

Authors:  N Ngo Mandag; M Van Gossum; F Rickaert; M Golstein
Journal:  Rev Med Brux       Date:  2007 Nov-Dec
View more
  6 in total

1.  Systemic sclerosis and autoimmune hepatitis.

Authors:  Cumali Efe; Tugrul Purnak; Ersan Ozaslan; Zeynep Ozbalkan
Journal:  Clin Rheumatol       Date:  2010-04-07       Impact factor: 2.980

2.  Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan.

Authors:  Reinhild Klein; Eva Hintz; Gerd Staehler
Journal:  BMJ Case Rep       Date:  2012-07-13

3.  Euforia-induced acute hepatitis in a patient with scleroderma.

Authors:  Esther Jiménez-Encarnación; Grissel Ríos; Angel Muñoz-Mirabal; Luis M Vilá
Journal:  BMJ Case Rep       Date:  2012-12-19

4.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Isabel M McFarlane; Manjeet S Bhamra; Alexandra Kreps; Sadat Iqbal; Firas Al-Ani; Carla Saladini-Aponte; Christon Grant; Soberjot Singh; Khalid Awwal; Kristaq Koci; Yair Saperstein; Fray M Arroyo-Mercado; Derek B Laskar; Purna Atluri
Journal:  Rheumatology (Sunnyvale)       Date:  2018-03-30

5.  Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome.

Authors:  Roberto Assandri; Marta Monari; Alessandro Montanelli
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

6.  Autoimmune Hepatitis and Systemic Sclerosis: a Rare Association.

Authors:  Elisabete Coelho; Ana Rita Matos; Sofia Caridade
Journal:  Eur J Case Rep Intern Med       Date:  2019-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.